Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 48 of Humacyte, Inc.'s SEC filings and found 9 warrant series, 1 convertible, 2 ATM programs, 1 equity line, 1 shelf registration and 4 completed offerings on file for HUMA. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
NBPNovaBridge Biosciences
CDXSCodexis, Inc.
NERVMinerva Neurosciences, Inc.
NMRANeumora Therapeutics, Inc. Common Stock
CHRSCoherus Oncology, Inc.
LENZLENZ Therapeutics, Inc.
PYPDPolyPid Ltd. Ordinary Shares
HURATuHURA Biosciences, Inc.
AVXLAnavex Life Sciences Corp.
SPRBSpruce Biosciences, Inc.
VYGRVoyager Therapeutics, Inc.
FHTXFoghorn Therapeutics Inc.
NKTXNkarta, Inc.
OTLKOutlook Therapeutics, Inc.
ARMPArmata Pharmaceuticals, Inc.